Vitamin D deficiency: what the diagnosis means and what the research does and doesn't show

Vitamin D deficiency is a diagnosis made by a blood test of 25-hydroxyvitamin D, not by symptoms, and the cut-offs are disputed. In 2024 the Endocrine Society withdrew its 30 ng/mL "sufficiency" line, saying trial evidence cannot set thresholds that predict benefit. Whether a level is low, and what to do, is a clinician's call.

What the evidence doesn't support

• Diagnosing yourself from symptoms. Low vitamin D often produces nothing noticeable, and the symptoms people search for (tiredness, aches, low mood, hair shedding, low iron or B12) have many other causes. No symptom list substitutes for a blood test.
• One agreed threshold. A 2020 review uses below 50 nmol/L (20 ng/mL) for deficiency and below 30 nmol/L (12 ng/mL) for severe deficiency, while a 2012 position statement put "optimal" at 75 to 225 nmol/L and said there was no international consensus. The Endocrine Society no longer endorses its 2011 definitions.
• Routine testing of everyone. The 2024 Endocrine Society guideline found no clinical-trial evidence to support routine 25(OH)D screening in the general population, including people with obesity or dark skin.
• A supplement as a cure for a list of symptoms. Trials in mostly vitamin-D-replete adults found no effect on many outcomes; the better-supported signals are in people who start very low, which a blood test identifies.
• A dose for deficiency from a web page. Treatment doses are set by a clinician from a measured level; we give no figure.

What the research found

How deficiency is defined, and why the lines moved

A 2020 narrative review in the European Journal of Clinical Nutrition defines deficiency as serum 25(OH)D below 50 nmol/L (20 ng/mL), calls below 30 nmol/L (12 ng/mL) severe, and links deficiency with unfavourable skeletal outcomes. It also says large trials have not shown a clear benefit of supplementation in mostly replete populations, and that vitamin D is most likely effective only in deficiency. It is a narrative review, so its thresholds are a position, not a trial result. The 2024 Endocrine Society guideline communication says the available trials do not permit 25(OH)D thresholds that specifically predict meaningful benefit, that the panel's certainty was very low, and that the Society no longer endorses its earlier 30 ng/mL (75 nmol/L) "sufficiency" or 20 to 30 ng/mL "insufficiency" definitions.

What a low level is linked with

A 2017 individual-participant meta-analysis of 25 randomised trials (11,321 people) found vitamin D lowered the odds of an acute respiratory infection overall (adjusted odds ratio 0.88, 95% CI 0.81 to 0.96). In people whose baseline level was below 25 nmol/L the odds ratio was 0.30, and 0.75 in those above it. That is the clearest sign that a benefit, where one exists, sits in people who start very low, and it is a respiratory-infection result in trial participants rather than a treatment instruction. A 2024 meta-analysis of 23 observational studies found lower vitamin D and more deficiency in people with non-scarring hair loss (odds ratio 3.11, 95% CI 2.29 to 4.22), an association that does not show cause; see does vitamin D help hair growth?.

Who tends to be low

A 2012 European Menopause and Andropause Society position statement lists the known influences on blood levels: season (lower in winter), latitude, altitude, air pollution, skin pigmentation, sunscreen use and clothing coverage, and risk factors including obesity, malabsorption syndromes, some medicines (such as anticonvulsants and antiretrovirals), skin ageing, low sun exposure and living in residential care. It also notes that the major natural source is skin synthesis in sunlight.

What treatment safety looks like

Because clinicians sometimes use high doses once a deficiency is measured, safety matters. A 2018 clinical review describes vitamin D toxicity as rare but serious, usually from inadvertent or improper intake of extremely high doses of concentrated preparations, with high blood calcium causing confusion, apathy, repeated vomiting, abdominal pain, frequent urination, thirst and dehydration; it is identified by 25(OH)D above about 150 ng/mL (375 nmol/L). A 2023 meta-analysis of 22 trials (12,952 adults, 3,200 to 4,000 IU of D3 a day for six months or more) found hypercalcemia more common than on control (relative risk 2.21, about 4 extra cases per 1,000). See how much vitamin D is too much.

Source	Position on thresholds
Review, Eur J Clin Nutr 2020	Deficiency below 50 nmol/L (20 ng/mL); severe below 30 nmol/L (12 ng/mL)
EMAS position statement 2012	"Optimal" 75 to 225 nmol/L; no international consensus
Endocrine Society, 2024	No longer endorses 75 nmol/L "sufficiency"; evidence cannot set thresholds that predict benefit

Questions people ask

What is vitamin D3 deficiency?

A low blood level of 25-hydroxyvitamin D, the form clinicians measure. Where exactly "low" begins is debated (see the table). A diagnosis is a clinician's judgment on a blood result, together with your health history. In US medical coding, uncomplicated vitamin D deficiency is recorded as ICD-10-CM code E55.9, a billing and records category, not a measure of severity.

What are the symptoms of vitamin D3 deficiency, and what does it cause?

Often none you would notice. The 2020 review links deficiency with unfavourable skeletal outcomes, including fractures and bone loss. The symptoms people list online overlap with many other things, so they cannot tell you your level; only the blood test can.

What causes vitamin D3 deficiency?

The influences listed by the 2012 position statement above: little sun, winter and high latitude, darker skin pigmentation, covering clothing or sunscreen, ageing skin, obesity, malabsorption, certain medicines and residential care.

How is it tested, and is there a blood test?

Yes: serum 25-hydroxyvitamin D. The Endocrine Society found no trial evidence for routine testing of the general population, so testing is for people with a reason, which a clinician decides.

Will vitamin D3 help with vitamin D deficiency?

The 2020 review treats a level above 50 nmol/L (20 ng/mL) as the primary treatment goal and says vitamin D is most likely effective only in deficiency; the respiratory-infection analysis points the same way, with the largest effect in people below 25 nmol/L. The dose and duration are a clinician's decision, based on your measured level, your health and other medicines. We give no dose. The question of daily amounts in general is in how much vitamin D should you take a day.

Can vitamin D3 deficiency cause hair loss, anemia, or affect B12?

Hair loss: an association in observational studies, not shown as a cause. Anemia and B12: we cite no study, so no statement is made; see vitamin D and iron for the iron pairing.

Is there a "cure" for vitamin D3 deficiency?

Treatment is a clinician's decision. Nothing on this page replaces it, and a supplement picked off a shelf is not a substitute for knowing your level first.

When to talk to a doctor

If you suspect your vitamin D is low, or you have a condition that affects absorption, a bone, kidney or calcium disorder, take medicines that alter vitamin D, or are pregnant or breastfeeding, ask a clinician about a test. Vitamin D is not a treatment for any of the symptoms searched above, and a supplement is not a way to diagnose or fix a deficiency without one. Do not combine several vitamin D products: the adult upper limit is 100 mcg (4,000 IU) a day from all sources.